U.S. market Closed. Opens in 12 hours 45 minutes

COEPW | Coeptis Therapeutics Holdings, Inc. Stock Financials Income Statements Annual

(Stock Exchange: NASDAQ)
*Sign In to persist settings
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-31
RevenueN/AN/A75.00K30.76KN/A
Cost of Revenue1.00M1.00M447.41K964.22KN/A
Gross Profit-1.00M-1.00M-372.41K-933.46KN/A
Operating Expenses20.49M34.20M14.12M5.78MN/A
Selling, General & Admin13.82M34.18M14.12M5.78MN/A
Research & Development6.67M20.89KN/A3.54KN/A
Other Operating ExpensesN/A233.70K785.79K-2.29MN/A
Operating Income-21.49M-34.20M-14.05M-6.86MN/A
Other Expenses / Income224.58K-3.38M596.65K-2.29M-2.23K
Before Tax Income-21.27M-37.57M-13.45M-9.16M-2.23K
Income Tax ExpensesN/A3.39M972.92K-2.15MN/A
Net Income-21.27M-40.97M-14.42M-7.01M-2.23K
Interest Expenses-107.69K218.41K187.13K148.19KN/A
Basic Shares Outstanding25.69M14.30M10.91M9.38M10.78M
Diluted Shares Outstanding25.69M14.30M10.91M9.38M10.78M
EBITDA-20.16M-36.35M-12.81M-8.68M171.86K
EBITDA Margin0.00%0.00%-17,086.32%-28,232.72%0.00%
EBIT-21.37M-37.36M-13.26M-9.01M-2.23K
EBIT Margin0.00%0.00%-17,682.86%-29,284.14%0.00%
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-31
An error has occurred. This application may no longer respond until reloaded. Reload 🗙